939
Views
11
CrossRef citations to date
0
Altmetric
Short Report

Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies

, , , , , , & show all
Pages 1836-1839 | Received 30 Jan 2015, Accepted 04 Apr 2015, Published online: 06 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Martina M. Ochs, Kimberley Williams, Anthony Sheung, Philippe Lheritier, Lucian Visan, Nicolas Rouleau, Emilie Proust, Aymeric de Montfort, Mei Tang, Karine Mari, Robert Hopfer, Scott Gallichan & Roger H. Brookes. (2016) A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge. Human Vaccines & Immunotherapeutics 12:11, pages 2946-2952.
Read now

Articles from other publishers (10)

Aaron D. Gingerich & Jarrod J. Mousa. (2022) Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies. Frontiers in Cellular and Infection Microbiology 12.
Crossref
M. V. Savkina, M. A. Krivykh, N. A. Gavrilova, L. V. Sayapina, Yu. I. Obukhov, V. A. Merkulov & V. P. Bondarev. (2021) Review of global use of licensed vaccines and development of new vaccines for the prevention of pneumococcal infection. BIOpreparations. Prevention, Diagnosis, Treatment 21:4, pages 234-243.
Crossref
Greiciely O. André, Mayara T. Borges, Lucas Assoni, Lucio F.C. Ferraz, Piplani Sakshi, Penelope Adamson, David L. Gordon, Abiodun D. Ogunniyi, Henrietta Venter, Thiago R. Converso & Michelle Darrieux. (2021) Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis. Vaccine 39:27, pages 3626-3632.
Crossref
Jiachen Huang, Aaron D. Gingerich, Fredejah Royer, Amy V. Paschall, Alma Pena-Briseno, Fikri Y. Avci & Jarrod J. Mousa. (2021) Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection. Infection and Immunity 89:5.
Crossref
Malihe Masomian, Zuleeza Ahmad, Lai Ti Gew & Chit Laa Poh. (2020) Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines 8:1, pages 132.
Crossref
Rajendra-Prasad Janapatla, Chyi-Liang Chen, Mei-Hua Hsu, Wan-Ting Liao & Cheng-Hsun Chiu. (2018) Immunization with pneumococcal neuraminidases NanA, NanB and NanC to generate neutralizing antibodies and to increase survival in mice. Journal of Medical Microbiology 67:5, pages 709-723.
Crossref
Theodora Papastamatiou, John G. Routsias, Olga Koutsoni, Eleni Dotsika, Athanassios Tsakris & Vana Spoulou. (2018) Evaluation of Protective Efficacy of Selected Immunodominant B-Cell Epitopes within Virulent Surface Proteins of Streptococcus pneumoniae. Infection and Immunity 86:3.
Crossref
Salvador F. Ausar, Kavisha Jayasundara, Lamees Akawi, Cristopher Roque, Anthony Sheung, Jian Hu, Marina Kirkitadze & Nausheen Rahman. (2017) Biophysical Characterization and Thermal Stability of Pneumococcal Histidine Triad Protein D in the Presence of Zinc and Manganese. Journal of Pharmaceutical Sciences 106:10, pages 2979-2987.
Crossref
Q. Xu, J.R. Casey, A. Almudevar & M.E. Pichichero. (2017) Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children. Clinical Microbiology and Infection 23:7, pages 487.e1-487.e6.
Crossref
Qingfu Xu, Karin Pryharski & Michael E. Pichichero. (2017) Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model. Vaccine 35:2, pages 337-344.
Crossref